If your Cartiva synthetic cartilage implant failed and you required revision fusion surgery, you may be entitled to significant financial compensation. With MDL 3172 consolidated in February 2026 and the first bellwether trial approaching in August 2026, now is the critical window to benchmark your potential damages before trial outcomes reshape settlement values across the litigation. This Cartiva implant failure damages calculator guide breaks down exactly how attorneys and courts value these claims — covering revision surgery costs, lost wages, pain and suffering tiers, and how MDL consolidation affects your negotiating position.
What Is the Cartiva MDL and Why Does It Matter for Your Damages?
Cartiva SCI (Synthetic Cartilage Implant) devices — small plugs of polyvinyl alcohol hydrogel inserted into the big toe joint — were marketed as a motion-preserving alternative to fusion surgery for hallux rigidus (big toe arthritis). For thousands of patients, the promise turned into a painful failure. Justia’s products liability framework for defective medical devices applies directly to these claims: when a device causes foreseeable harm due to design or manufacturing defects, manufacturers bear strict liability.
Cartiva cases were consolidated into MDL 3172 in February 2026, placing all federal claims before one judge for coordinated pretrial proceedings. As of April 2026, 14 lawsuits are pending in the MDL, with mediation ongoing since March 2026 and a bellwether trial date potentially set for August 17, 2026. This matters enormously for your individual claim: bellwether trials serve as financial weather vanes — the jury verdict in the first trial will anchor settlement negotiations for every subsequent plaintiff.
Stryker’s October 2024 recall of Cartiva devices, citing failure rates that exceeded FDA approval assumptions, significantly strengthened plaintiffs’ positions by establishing that even the manufacturer acknowledged the device was defective. The MDL’s coordination means your attorney can leverage shared discovery, pooled expert witnesses, and collective bargaining power that individual lawsuits simply cannot match.
How the Cartiva Implant Failure Damages Calculator Works
Our Cartiva implant failure damages calculator is built around the three core categories that courts and defense attorneys use to value these specific claims. Unlike general personal injury valuations, Cartiva claims carry distinctive damage profiles because the failure mechanism — a shrinking hydrogel plug that destabilizes the entire metatarsophalangeal joint — creates a highly predictable cascade of medical, economic, and quality-of-life harms. Understanding each category is essential before you can accurately estimate your settlement range.
Category 1: Medical Costs and Revision Surgery Expenses
The primary economic anchor in any Cartiva claim is the cost of revision surgery. When the polyvinyl alcohol hydrogel shrinks after implantation, the device loosens and shifts within the joint, causing bone erosion, inflammation, nerve irritation, and progressive joint instability. The only corrective option in most cases is complete surgical removal of the Cartiva device followed by arthrodesis — the fusion surgery patients were trying to avoid in the first place.
Revision fusion surgery typically costs significantly more than the original implant procedure due to bone loss, scarring, and the complexity of working around a failed implant site. Bureau of Labor Statistics data on orthopedic surgeon compensation helps contextualize facility and professional fee benchmarks. Below is the standard medical cost framework this calculator uses for Cartiva failure claims in 2026:
| Damage Component | Estimated Range (2026) | Notes |
|---|---|---|
| Revision fusion surgery (facility + surgeon fees) | $28,000 – $65,000 | Higher end for complex bone graft cases |
| Anesthesia costs | $1,500 – $4,500 | Duration-dependent |
| Post-operative imaging (X-ray, MRI) | $800 – $3,200 | Multiple follow-up scans typical |
| Physical/occupational therapy | $4,000 – $12,000 | 12–24 weeks average recovery |
| Prescription medications and orthotics | $600 – $2,400 | Ongoing pain management |
| Future medical care (permanent complications) | $8,000 – $40,000+ | Nerve damage, arthritis management |
| Total Medical Costs (Typical Range) | $42,900 – $127,100 | Per-plaintiff estimate |
One plaintiff in the MDL alleges that a Cartiva SCI implanted in 2019 failed and required surgical removal in 2023 — a four-year period during which the manufacturer allegedly had prior knowledge of over 100 adverse event reports of loosening or failure. This prior knowledge is critical to damages: it supports punitive damages claims and undermines any defense argument that the failure was unforeseeable.
Category 2: Lost Wages and Earning Capacity Losses
Big toe joint fusion surgery is not a minor procedure. Recovery typically involves six to twelve weeks of non-weight-bearing status, followed by months of restricted activity. For patients in physically demanding occupations — construction, nursing, food service, retail, law enforcement — the economic impact can be severe. Our Cartiva implant failure damages calculator computes lost wages using three tiers:
- Tier 1 — Sedentary/Remote Workers: 6–10 weeks of partial disability; estimated wage loss of $4,000 – $18,000 depending on income level
- Tier 2 — Mixed-Duty Employees: 10–20 weeks of significant restriction; estimated wage loss of $12,000 – $45,000
- Tier 3 — Heavy Physical Labor: 20+ weeks of total or near-total disability plus potential permanent capacity reduction; estimated wage loss of $30,000 – $120,000+
Where Cartiva failure causes permanent nerve damage, chronic pain, or loss of toe mobility — common outcomes given how the hydrogel’s shrinkage erodes surrounding bone — attorneys calculate diminished earning capacity over the plaintiff’s remaining working years. This figure can dwarf the direct wage loss calculation, particularly for plaintiffs under 55 in physically demanding careers. Settlements in medical device mass torts typically account for costs of revision surgeries, lost wages, and permanent physical impairment as core valuation elements.
Category 3: Pain, Suffering, and Quality-of-Life Damages
Non-economic damages represent the most variable — and often the largest — component of a Cartiva claim. Courts and mediators evaluate pain and suffering in these cases across a spectrum that accounts for duration of suffering before revision surgery, permanence of any residual impairment, and the plaintiff’s pre-injury lifestyle and activity level.
Our Cartiva implant failure damages calculator uses a tiered multiplier model consistent with how defense actuaries and plaintiff attorneys value similar medical device claims in 2026. Unlike a slip and fall calculator, where liability and causation are often disputed, Cartiva claims benefit from a product recall that effectively concedes defect — which typically supports higher multipliers:
- Mild Tier (1.5x–2.5x economic damages): Implant failed within 2–3 years; revision surgery successful; minimal residual impairment
- Moderate Tier (2.5x–4x economic damages): Prolonged suffering before diagnosis; partial permanent impairment; altered work/lifestyle capacity
- Severe Tier (4x–6x+ economic damages): Extensive nerve damage; bone erosion requiring grafting; permanent mobility loss; psychological impact
MDL Consolidation and Its Effect on Settlement Leverage
Understanding MDL 3172’s structure is essential to using any Cartiva implant failure damages calculator accurately. Multi-District Litigation does not guarantee a class action settlement — each plaintiff retains an individual claim. However, MDL coordination dramatically reshapes the settlement negotiation environment in ways that typically benefit plaintiffs who understand the dynamics.
With the August 2026 bellwether trial approaching, Stryker faces a critical strategic decision: allow a jury to set a public damages benchmark that will anchor thousands of future claims, or reach a global mediated resolution that caps per-plaintiff payouts at a negotiated level. Mediation ongoing since March 2026 signals that both sides are actively testing that calculus. Nolo’s explanation of MDL litigation mechanics details how bellwether verdicts create settlement pressure across an entire consolidated docket.
For plaintiffs in MDL 3172, the pre-trial window — right now, in July 2026 — is historically the highest-leverage moment. Defense counsel is acutely aware that a single sympathetic jury verdict can multiply settlement expectations exponentially. Plaintiffs who have completed medical treatment, documented their losses thoroughly, and engaged qualified legal counsel are positioned to negotiate from maximum strength before the trial either validates or moderates plaintiff expectations. This dynamic also parallels other defective device litigations, such as hip implant and hernia mesh MDLs, where pre-bellwether settlements consistently exceeded post-trial averages for latecomers.
Factors That Adjust Your Individual Damages Estimate
No two Cartiva implant failure claims are identical. Several factors will push your estimated settlement value above or below the ranges described in this Cartiva implant failure damages calculator:
Factors That Increase Claim Value
- Early implantation date with documented adverse events before surgery: If your implant predates Stryker’s internal adverse event reports of over 100 loosening/failure incidents, the concealment argument strengthens punitive exposure
- Severe bone erosion requiring bone grafting: Dramatically increases surgical complexity, recovery time, and permanence of impairment
- Bilateral failure (both feet): Doubles most economic loss calculations and multiplies pain and suffering damages
- Pre-injury active lifestyle or athletic history: Courts award higher non-economic damages when plaintiffs can demonstrate concrete quality-of-life deprivation
- Permanent nerve damage: Chronic neuropathic pain claims carry significant long-term cost projections
Factors That May Reduce Claim Value
- Prior toe or foot conditions: Defense attorneys will argue pre-existing arthritis contributed to failure
- Delayed revision surgery: Gaps in treatment create arguments that plaintiff failed to mitigate damages
- Limited documentation of wage loss: Self-employed plaintiffs face higher scrutiny on economic damages without tax records and client documentation
For perspective, injuries that alter mobility and independence — particularly those affecting a plaintiff’s ability to work and engage in daily activities — are assessed through frameworks similar to those used in serious accident claims. Just as a car accident settlement calculator weighs permanence of impairment heavily in mobility-affecting injuries, Cartiva claims are strongest when medical records clearly document the trajectory from implant to failure to surgical correction to residual deficit.
What Cartiva Plaintiffs Need to Document Before Using This Calculator
Accuracy in any Cartiva implant failure damages calculator depends entirely on the completeness of your records. Before attempting to estimate your claim value — and especially before entering mediation — gather the following:
- Original implant surgical records including device lot number, implantation date, and surgeon’s operative notes
- All post-implantation imaging (X-rays and MRIs showing device migration, shrinkage, bone erosion)
- Revision surgery records including pathology reports if tissue samples were collected
- Complete billing records from all treating facilities — do not rely on insurance EOBs alone
- Wage documentation: Two years of pre-injury tax returns, pay stubs, employer records of missed work
- Personal injury journal: Daily written records of pain levels, activity limitations, and emotional impact significantly strengthen pain and suffering claims
- Proof of Stryker device: Manufacturer, model designation “Cartiva SCI,” and implant size if available from operative report
Cornell Law School’s Legal Information Institute on products liability provides an authoritative overview of the legal standards — including strict liability, negligence, and breach of warranty — that underlie Cartiva implant failure claims. Understanding which theory applies to your specific facts affects how damages are pled and presented to a mediator or jury.
Frequently Asked Questions About Cartiva Implant Failure Damages
What is the average settlement value for a Cartiva implant failure claim in 2026?
No official average settlement figure exists for MDL 3172 because the litigation is in early stages, with the first bellwether trial scheduled for August 2026 and global mediation ongoing since March 2026. However, based on comparable medical device mass torts involving revision surgeries, lost wages, and permanent impairment, individual claim estimates for Cartiva failures with revision fusion surgery typically range from $75,000 to over $400,000 depending on severity, permanence of injury, and the plaintiff’s economic profile. Using our Cartiva implant failure damages calculator with your specific documented losses will produce a more individualized estimate.
Does Stryker’s October 2024 recall strengthen my Cartiva lawsuit?
Yes, significantly. Product recalls are not admissible as proof of negligence in every jurisdiction, but they serve as powerful evidence of defect acknowledgment and are highly persuasive in mediation. Stryker’s recall, citing failure rates exceeding FDA approval assumptions, directly contradicts any defense argument that the device performed within expected parameters. Plaintiffs whose implants were placed before the recall but after Stryker’s internal adverse event data showed over 100 reports of loosening or failure are particularly well-positioned to argue that the company concealed known risks — a fact pattern that supports both compensatory and punitive damages claims.
How does MDL 3172 affect my individual Cartiva case?
MDL consolidation places your case before a single federal judge for coordinated pretrial proceedings — including shared discovery, joint expert witnesses, and collective bellwether trials. This does not merge your individual claim into a class action. You retain a separate lawsuit and negotiate your own settlement. MDL coordination benefits you by dramatically reducing litigation costs, accelerating access to Stryker’s internal documents, and creating group settlement leverage that individual plaintiffs cannot achieve alone. The August 2026 bellwether trial will produce a jury verdict that effectively anchors settlement negotiations for all remaining plaintiffs in the MDL.
What types of complications qualify my Cartiva failure as a serious injury claim?
Common problems documented in Cartiva MDL claims include polyvinyl alcohol hydrogel shrinking after implantation, causing the device to loosen and shift within the joint. This leads to joint instability, nerve damage, severe chronic pain, bone erosion, significant inflammation, and permanent loss of toe mobility. Any Cartiva recipient who experienced these complications and required revision fusion surgery qualifies for damages consideration. Plaintiffs with permanent nerve damage, extensive bone erosion requiring grafting, or bilateral implant failure generally occupy the highest damage tiers in this Cartiva implant failure damages calculator framework.
Is it too late to join the Cartiva MDL if I haven’t filed yet?
As of July 2026, it is not too late to file a Cartiva implant failure lawsuit, though timing matters strategically. Plaintiffs who file and engage in the MDL before the August 2026 bellwether verdict have maximum leverage in pre-trial mediation. After a bellwether verdict — whether plaintiff-favorable or defense-favorable — settlement values across the entire MDL shift to reflect that outcome, sometimes dramatically. Additionally, state statutes of limitations for medical device product liability claims vary by state, typically ranging from two to six years from discovery of injury. Consulting qualified legal counsel promptly protects your right to participate in the current litigation window.
Legal disclaimer: The information provided on this page is for general informational and educational purposes only and does not constitute legal advice; consult a licensed attorney in your jurisdiction for advice specific to your Cartiva implant failure claim.
James Mitchell is a personal injury legal researcher with over a decade of experience analyzing settlement data and compensation trends across the United States. He has studied thousands of personal injury cases to help injury victims understand their legal rights and the potential value of their claims. James is not an attorney and the information he provides is for
educational purposes only.